- Home
- QBTS vs IKT Comparison
QBTS vs IKT Comparison
Compare QBTS & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QBTS
- IKT
- Stock Information
- Founded
- QBTS 1999
- IKT 2008
- Country
- QBTS Canada
- IKT United States
- Employees
- QBTS N/A
- IKT N/A
- Industry
- QBTS Retail: Computer Software & Peripheral Equipment
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- QBTS Technology
- IKT Health Care
- Exchange
- QBTS Nasdaq
- IKT Nasdaq
- Market Cap
- QBTS 194.5M
- IKT 159.2M
- IPO Year
- QBTS N/A
- IKT 2020
- Fundamental
- Price
- QBTS $1.64
- IKT $2.05
- Analyst Decision
- QBTS Strong Buy
- IKT Strong Buy
- Analyst Count
- QBTS 6
- IKT 2
- Target Price
- QBTS $2.63
- IKT $6.50
- AVG Volume (30 Days)
- QBTS 11.9M
- IKT 359.9K
- Earning Date
- QBTS 11-14-2024
- IKT 11-14-2024
- Dividend Yield
- QBTS N/A
- IKT N/A
- EPS Growth
- QBTS N/A
- IKT N/A
- EPS
- QBTS N/A
- IKT N/A
- Revenue
- QBTS $9,424,000.00
- IKT $1.00
- Revenue This Year
- QBTS $17.54
- IKT N/A
- Revenue Next Year
- QBTS $95.85
- IKT N/A
- P/E Ratio
- QBTS N/A
- IKT N/A
- Revenue Growth
- QBTS 14.27
- IKT N/A
- 52 Week Low
- QBTS $0.68
- IKT $0.80
- 52 Week High
- QBTS $2.44
- IKT $3.82
- Technical
- Relative Strength Index (RSI)
- QBTS 63.60
- IKT 42.19
- Support Level
- QBTS $0.98
- IKT $2.56
- Resistance Level
- QBTS $2.15
- IKT $3.69
- Average True Range (ATR)
- QBTS 0.21
- IKT 0.34
- MACD
- QBTS 0.06
- IKT -0.10
- Stochastic Oscillator
- QBTS 56.54
- IKT 5.75
About QBTS D-Wave Quantum Inc.
D-Wave Quantum Inc is engaged in the development and delivery of quantum computing systems, software, and services, and is the commercial supplier of quantum computers—and the only company building both annealing quantum computers and gate-model quantum computers. The Company's mission is to unlock the power of quantum computing today to benefit business and society. D-Wave does this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modelling. D-Wave's annealing quantum computers are accessible through the Company's LeapTM cloud service.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.